Search results
Author(s):
Elisabetta Bigagli
,
Jacopo Angelini
,
Alessandro Mugelli
,
et al
Added:
7 months ago
Author(s):
Maki Komiyama
,
Moritake Iguchi
,
Hiromichi Wada
,
et al
Added:
1 year ago
Author(s):
Christie Ballantyne
Added:
2 months ago
AHA Scientific Sessions 2025 - Dr Christie Ballantyne (Baylor College of Medicine, Houston, TX, US) discusses findings from the CORALreef HeFH trial, examining the efficacy and safety of enlicitide decanoate, an oral PCSK9 inhibitor, in adults with heterozygous familial hypercholesterolemia.This Phase 3, randomized, double-blind, placebo-controlled study evaluated 303 participants with…
View more
Author(s):
Byoung Geol Choi
,
Seung-Woon Rha
,
Se Yeon Choi
,
et al
Added:
1 year ago
Author(s):
Frederick Raal
Added:
2 years ago
ESC 23 — Prof Frederick Raal (University of the Witwatersrand, Johannesburg, SA) outlines the late-breaking results from the LIBerte-HeFH study (NCT04797104).
The phase III LIBerte-HeFH study (LIB Therapeutics LLC) aimed to assess the effectiveness of PCSK9-inhibitor Ierodalcibep (LIB003) in reducing low-density lipoprotein cholesterol (LDL-C) in 300mg doses administered subcutaneously in…
View more
Luca Testa
Research Area(s) / Expertise:
Author
Expertise
Carlo Patrono
Research Area(s) / Expertise:
Author
Expertise
Author(s):
Dirk Sibbing
,
Michael J Blaha
,
Rajinder Chawla
,
et al
Added:
1 year ago
Mario Petretta
Research Area(s) / Expertise:
Author